The 2024 asco annual meeting program featured over 200 sessions complementing dr. New melanoma treatments, blockbuster lung cancer data, and resurrected blood cancer drugs feature at the conference.
Julie gralow, asco’s chief medical officer, on the results of the nadina trial—lba2 from the 2024 plenary. By melanie farrell, asco publishing.
The 2024 Asco Annual Meeting Program Featured Over 200 Sessions Complementing Dr.
The drug, blenrep, was pulled from the market in 2022 after a failed study, but it recently hit its goals in two key trials.
Ballinger Shares Her Top News From Asco 2024.
Highlights of these data presented at asco 2024 are as follows:
Images References :
As The Stage Is Set For Another Year Of Novel Research, Transformative Breakthroughs In Treatments, And Visionary Insights,.
New melanoma treatments, blockbuster lung cancer data, and resurrected blood cancer drugs feature at the conference.
The 2024 Asco Annual Meeting Program Featured Over 200 Sessions Complementing Dr.